ET-1 from endothelial cells is required for complete angiotensin II-induced cardiac fibrosis and hypertrophy

Amiri, 2004, Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction, Circulation, 110, 2233, 10.1161/01.CIR.0000144462.08345.B9

Barton, 1998, Differential modulation of the renal and myocardial endothelin system by angiotensin II in vivo. Effects of chronic selective ETA receptor blockade, J Cardiovasc Pharmacol, 31, S265, 10.1097/00005344-199800001-00075

Bianciotti, 2000, Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension, Am J Physiol Heart Circ Physiol, 279, H93, 10.1152/ajpheart.2000.279.1.H93

Chintalgattu, 2004, Role of protein kinase Cdelta in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction, J Pharmacol Exp Ther, 311, 691, 10.1124/jpet.104.070151

Chintalgattu, 2009, Role of protein kinase C-delta in angiotensin II induced cardiac fibrosis, Biochem Biophys Res Commun, 386, 612, 10.1016/j.bbrc.2009.06.076

Chujo, 2005, Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model, J Cell Physiol, 203, 447, 10.1002/jcp.20251

Essick, 2011, Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling, Am J Physiol Heart Circ Physiol, 301, H984, 10.1152/ajpheart.00428.2011

Ferreira, 2010, betaIIPKC and epsilonPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failure, J Mol Cell Cardiol, 51, 479, 10.1016/j.yjmcc.2010.10.020

Fujisaki, 1995, Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression, J Clin Invest, 96, 1059, 10.1172/JCI118092

Gao, 2009, K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function, Cardiovasc Res, 83, 444, 10.1093/cvr/cvp099

Gonzalez, 2004, Fibrosis in hypertensive heart disease: role of the renin–angiotensin–aldosterone system, Med Clin North Am, 88, 83, 10.1016/S0025-7125(03)00125-1

Gray, 1998, Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts, Cardiovasc Res, 40, 352, 10.1016/S0008-6363(98)00121-7

Guo, 2006, Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade, J Hypertens, 24, 1097, 10.1097/01.hjh.0000226200.73065.5d

Harada, 1997, Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes, Circulation, 96, 3737, 10.1161/01.CIR.96.10.3737

Heidkamp, 2001, Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes, Circ Res, 89, 882, 10.1161/hh2201.099434

Herizi, 1998, Prevention of the cardiovascular and renal effects of angiotensin II by endothelin blockade, Hypertension, 31, 10, 10.1161/01.HYP.31.1.10

Holtz, 1993, Pathophysiology of heart failure and the renin–angiotensin–system, Basic Res Cardiol, 88, 183

Inagaki, 2008, Pharmacological inhibition of epsilon-protein kinase C attenuates cardiac fibrosis and dysfunction in hypertension-induced heart failure, Hypertension, 51, 1565, 10.1161/HYPERTENSIONAHA.107.109637

Ito, 1993, Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes, J Clin Invest, 92, 398, 10.1172/JCI116579

Kedzierski, 2003, Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol, Mol Cell Biol, 23, 8226, 10.1128/MCB.23.22.8226-8232.2003

Kimura, 2005, Role of NAD(P)H oxidase- and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II, Hypertension, 45, 860, 10.1161/01.HYP.0000163462.98381.7f

Kisanuki, 2010, Low blood pressure in endothelial cell-specific endothelin 1 knockout mice, Hypertension, 56, 121, 10.1161/HYPERTENSIONAHA.109.138701

Klein, 2005, Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon, Circ Res, 96, 748, 10.1161/01.RES.0000161999.86198.1e

Leask, 2010, Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation, Circ Res, 106, 1675, 10.1161/CIRCRESAHA.110.217737

Leivonen, 2005, Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts, J Invest Dermatol, 124, 1162, 10.1111/j.0022-202X.2005.23750.x

Liu, 1999, Potential role of the microvasculature in progression of heart failure, Am J Cardiol, 84, 23L, 10.1016/S0002-9149(99)00361-6

Markou, 2006, Regulation of protein kinase C delta by phorbol ester, endothelin-1, and platelet-derived growth factor in cardiac myocytes, J Biol Chem, 281, 8321, 10.1074/jbc.M508398200

Nishida, 1993, Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture, J Clin Invest, 91, 1934, 10.1172/JCI116412

Olson, 2008, Angiotensin II-induced extracellular signal-regulated kinase 1/2 activation is mediated by protein kinase Cdelta and intracellular calcium in adult rat cardiac fibroblasts, Hypertension, 51, 704, 10.1161/HYPERTENSIONAHA.107.098459

Peng, 2003, Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension, Hypertension, 42, 1164, 10.1161/01.HYP.0000100423.24330.96

Prasad, 2003, Abnormal coronary microvascular endothelial function in humans with asymptomatic left ventricular dysfunction, Am Heart J, 146, 549, 10.1016/S0002-8703(03)00364-8

Pucéat, 1994, Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes, J Biol Chem, 269, 16938, 10.1016/S0021-9258(19)89480-2

Rodriguez-Vita, 2005, Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells, Circ Res, 97, 125, 10.1161/01.RES.0000174614.74469.83

Ruperez, 2003, Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis, Circulation, 108, 1499, 10.1161/01.CIR.0000089129.51288.BA

Schultz, 2002, TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II, J Clin Invest, 109, 787, 10.1172/JCI0214190

Schwarz, 2002, Tissue-dependent expression of matrix proteins in human endothelin-1 transgenic mice, Clin Sci (Lond), 103, 39S, 10.1042/CS103S039S

Shimojo, 2006, Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK, Am J Physiol Heart Circ Physiol, 291, H835, 10.1152/ajpheart.01365.2005

Stawowy, 2005, Protein kinase C epsilon mediates angiotensin II-induced activation of beta1-integrins in cardiac fibroblasts, Cardiovasc Res, 67, 50, 10.1016/j.cardiores.2005.03.002

van Wamel, 2002, Stretch-induced paracrine hypertrophic stimuli increase TGF-beta1 expression in cardiomyocytes, Mol Cell Biochem, 236, 147, 10.1023/A:1016138813353

Widyantoro, 2010, Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition, Circulation, 121, 2407, 10.1161/CIRCULATIONAHA.110.938217

Yoon, 2010, The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis, J Mol Cell Cardiol, 49, 294, 10.1016/j.yjmcc.2010.04.010

Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med, 13, 952, 10.1038/nm1613

Zeng, 2008, Endothelin-1 regulates cardiac L-type calcium channels via NAD(P)H oxidase-derived superoxide, J Pharmacol Exp Ther, 326, 732, 10.1124/jpet.108.140301